CN113081933A - Acne-removing composition and preparation method and application thereof - Google Patents
Acne-removing composition and preparation method and application thereof Download PDFInfo
- Publication number
- CN113081933A CN113081933A CN202110388109.7A CN202110388109A CN113081933A CN 113081933 A CN113081933 A CN 113081933A CN 202110388109 A CN202110388109 A CN 202110388109A CN 113081933 A CN113081933 A CN 113081933A
- Authority
- CN
- China
- Prior art keywords
- extract
- acne
- weight
- equal
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 92
- 206010000496 acne Diseases 0.000 title claims abstract description 92
- 239000000203 mixture Substances 0.000 title claims abstract description 63
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 239000000284 extract Substances 0.000 claims abstract description 113
- 239000003814 drug Substances 0.000 claims abstract description 30
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims abstract description 17
- 229940052016 turmeric extract Drugs 0.000 claims abstract description 14
- 235000020240 turmeric extract Nutrition 0.000 claims abstract description 14
- 239000008513 turmeric extract Substances 0.000 claims abstract description 14
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 12
- 239000006071 cream Substances 0.000 claims abstract description 8
- 244000061408 Eugenia caryophyllata Species 0.000 claims abstract description 5
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims description 14
- 125000003158 alcohol group Chemical group 0.000 claims description 12
- 244000132619 red sage Species 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 10
- 239000000341 volatile oil Substances 0.000 claims description 9
- 238000011282 treatment Methods 0.000 claims description 8
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 claims description 6
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims description 6
- 244000163122 Curcuma domestica Species 0.000 claims description 5
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 5
- 241000246044 Sophora flavescens Species 0.000 claims description 5
- 235000003373 curcuma longa Nutrition 0.000 claims description 5
- 239000006210 lotion Substances 0.000 claims description 5
- 235000013976 turmeric Nutrition 0.000 claims description 5
- 238000000855 fermentation Methods 0.000 claims description 4
- 230000004151 fermentation Effects 0.000 claims description 4
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 claims description 3
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 claims description 3
- 240000007164 Salvia officinalis Species 0.000 claims description 3
- 229930183118 Tanshinone Natural products 0.000 claims description 3
- FZPYMZUVXJUAQA-ZDUSSCGKSA-N Turmerone Chemical compound CC(C)=CC(=O)C[C@H](C)C1=CCC(C)=CC1 FZPYMZUVXJUAQA-ZDUSSCGKSA-N 0.000 claims description 3
- FZPYMZUVXJUAQA-UHFFFAOYSA-N Turmerone Natural products CC(C)=CC(=O)CC(C)C1=CCC(C)=CC1 FZPYMZUVXJUAQA-UHFFFAOYSA-N 0.000 claims description 3
- XOCANRBEOZQNAQ-KBPBESRZSA-N alpha-turmerone Natural products O=C(/C=C(\C)/C)C[C@H](C)[C@H]1C=CC(C)=CC1 XOCANRBEOZQNAQ-KBPBESRZSA-N 0.000 claims description 3
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 claims description 3
- 150000004056 anthraquinones Chemical class 0.000 claims description 3
- 235000012754 curcumin Nutrition 0.000 claims description 3
- 229940109262 curcumin Drugs 0.000 claims description 3
- 239000004148 curcumin Substances 0.000 claims description 3
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 claims description 3
- 229930003935 flavonoid Natural products 0.000 claims description 3
- 150000002215 flavonoids Chemical class 0.000 claims description 3
- 235000017173 flavonoids Nutrition 0.000 claims description 3
- 229930014456 matrine Natural products 0.000 claims description 3
- 230000000813 microbial effect Effects 0.000 claims description 3
- 235000005412 red sage Nutrition 0.000 claims description 3
- 239000000758 substrate Substances 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 2
- 244000299790 Rheum rhabarbarum Species 0.000 claims 3
- 210000002966 serum Anatomy 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 23
- 239000002537 cosmetic Substances 0.000 abstract description 16
- 230000003020 moisturizing effect Effects 0.000 abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 7
- 238000005562 fading Methods 0.000 abstract description 5
- 208000026935 allergic disease Diseases 0.000 abstract description 4
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 3
- 230000007815 allergy Effects 0.000 abstract description 3
- 239000000839 emulsion Substances 0.000 abstract description 3
- 206010040844 Skin exfoliation Diseases 0.000 abstract description 2
- 238000004140 cleaning Methods 0.000 abstract description 2
- 230000035618 desquamation Effects 0.000 abstract description 2
- 238000009472 formulation Methods 0.000 abstract description 2
- 230000036620 skin dryness Effects 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 230000008859 change Effects 0.000 description 69
- 210000003491 skin Anatomy 0.000 description 32
- 230000000052 comparative effect Effects 0.000 description 22
- 238000012360 testing method Methods 0.000 description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 244000223014 Syzygium aromaticum Species 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 11
- 241000219061 Rheum Species 0.000 description 11
- 210000004185 liver Anatomy 0.000 description 11
- 239000002674 ointment Substances 0.000 description 10
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical group CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 8
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 208000035475 disorder Diseases 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000001575 pathological effect Effects 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 244000215068 Acacia senegal Species 0.000 description 4
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 229920000084 Gum arabic Polymers 0.000 description 4
- 235000010489 acacia gum Nutrition 0.000 description 4
- 239000000205 acacia gum Substances 0.000 description 4
- 229960000458 allantoin Drugs 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 206010061876 Obstruction Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 208000020154 Acnes Diseases 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 241000186427 Cutibacterium acnes Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical class OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- WERKSKAQRVDLDW-ANOHMWSOSA-N [(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO WERKSKAQRVDLDW-ANOHMWSOSA-N 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000002390 adhesive tape Substances 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 230000003255 anti-acne Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229960003444 immunosuppressant agent Drugs 0.000 description 2
- 239000003018 immunosuppressive agent Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- -1 mask Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 229940055019 propionibacterium acne Drugs 0.000 description 2
- 208000020016 psychiatric disease Diseases 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000001732 sebaceous gland Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 235000010487 tragacanth Nutrition 0.000 description 2
- 239000000196 tragacanth Substances 0.000 description 2
- 229940116362 tragacanth Drugs 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 201000003126 Anuria Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 1
- 208000014085 Chronic respiratory disease Diseases 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 240000004980 Rheum officinale Species 0.000 description 1
- 235000008081 Rheum officinale Nutrition 0.000 description 1
- 239000009724 Salvia extract Substances 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000008365 aqueous carrier Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000037125 natural defense Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 229940127234 oral contraceptive Drugs 0.000 description 1
- 239000003539 oral contraceptive agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- ZLVSYODPTJZFMK-UHFFFAOYSA-M sodium 4-hydroxybenzoate Chemical compound [Na+].OC1=CC=C(C([O-])=O)C=C1 ZLVSYODPTJZFMK-UHFFFAOYSA-M 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 229940100615 topical ointment Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9755—Gymnosperms [Coniferophyta]
- A61K8/9761—Cupressaceae [Cypress family], e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
The invention relates to the technical field of traditional Chinese medicines and traditional Chinese medicine cosmetics, and particularly relates to an acne-removing composition and a preparation method and application thereof. The acne-removing composition comprises the following components in parts by weight: 0.01-0.5 part of turmeric extract, 0.01-0.3 part of clove extract, 0.02-1 part of salvia miltiorrhiza extract and 0.01-0.3 part of cacumen biotae extract. The composition has high safety, and can not cause skin dryness, desquamation, allergy, and dependence. Meanwhile, the composition has a remarkable acne removing effect and has the effects of moisturizing and acne mark fading. The prepared active extract has light color and good stability, and can achieve the effect by low-content application. The acne-removing traditional Chinese medicine composition is simple and convenient to apply, can be directly applied to cosmetics in various formulations, is not limited to products such as face cleaning products, water products, emulsion products, face cream products, essence products and the like, is low in formula cost, and has wide application prospects.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines and traditional Chinese medicine cosmetics, and particularly relates to an acne-removing composition and a preparation method and application thereof.
Background
Acne, commonly referred to as acne, is a chronic inflammatory skin disease that occurs well in adolescence and mainly involves the pilosebaceous unit of the face. The pathogenesis of acne has not yet been fully elucidated, and the currently known pathogenesis is mainly the following four: 1 hormone-induced excessive secretion of lipids from sebaceous glands in a genetic background; 2 follicular sebaceous gland duct keratosis; 3, breeding hair follicle microorganisms such as propionibacterium acnes; inflammation and immune response.
Cosmetics developed for acne are generally called acne-removing cosmetics. Aiming at the pathogenesis, the current commercially available acne-removing cosmetics usually achieve the effect by adding vitamin A and chemical bacteriostat (such as sulfur and salicylic acid). However, these ingredients tend to cause dryness, irritation or damage to the normal flora of the skin, and have poor consumer compliance. Moreover, the effect is achieved by adding forbidden substances (such as antibiotics such as chloramphenicol and the like, heavy metals and the like), and deeper damage is brought to the skin and even the mind of consumers.
The traditional Chinese medicine for treating acne has a long history in China, has wide sources of raw materials, low price and small toxic and side effects, and has obvious advantages in preparation of acne medicines. Therefore, the application of the traditional Chinese medicine in the acne-removing cosmetics is also an industrial research and development hotspot. However, the content of effective substances and the function condition of the acne removing efficacy of the acne removing cosmetics using the traditional Chinese medicine extract in the current market are not proved by scientific and rigorous data. Most of the acne removing cosmetics only stay at the level of concept addition, and whether the acne removing products have remarkable efficacy and whether the acne removing cosmetics are safe for human bodies cannot be guaranteed. The traditional Chinese medicine composition is mostly dark or light, but has poor stability, and can change color with time to cause inactivation. In addition, the addition amount of the traditional Chinese medicine composition in the cosmetic really having the acne removing effect is large, the cost is high, and the application is limited.
In view of the above, the present invention is particularly proposed.
Disclosure of Invention
In order to achieve the above purpose of the present invention, the following technical solutions are adopted:
the first aspect of the invention relates to an acne-removing composition which comprises the following components in parts by weight:
0.01-0.5 part of turmeric extract, 0.01-0.3 part of clove extract, 0.02-1 part of salvia miltiorrhiza extract and 0.01-0.3 part of cacumen biotae extract.
Optionally, the acne-removing composition comprises the following components by weight:
0.1-0.2 part of turmeric extract, 0.05-0.15 part of clove extract, 0.1-0.5 part of salvia miltiorrhiza extract and 0.05-0.15 part of cacumen biotae extract.
Optionally, in the acne-removing composition, the turmeric extract is a microbial fermentation product using turmeric as a substrate, and the total amount of curcumin and turmerone is more than or equal to 10% (w/w);
the clove extract is an alcohol extract, and the volatile oil is more than or equal to 8 percent;
the red sage root extract is an alcohol extract, and the tanshinone content is more than or equal to 5 percent;
the cacumen biotae extract is an alcohol extract, and the flavonoid substance is more than or equal to 3 percent.
Optionally, the acne-removing composition as described above further comprises the following components by weight:
0.01 to 0.5 part of rhizoma atractylodis extract, 0.01 to 0.5 part of rhubarb extract, 0.01 to 0.7 part of radix sophorae flavescentis extract and 0.01 to 0.3 part of rhizoma cyperi extract.
Optionally, the acne-removing composition as described above further comprises the following components by weight:
0.1-0.2 part of rhizoma atractylodis extract, 0.1-0.2 part of rhubarb extract, 0.1-0.3 part of radix sophorae flavescentis extract and 0.05-0.15 part of rhizoma cyperi extract.
Optionally, in the acne-removing composition, the rhizoma atractylodis extract is steam distillate, and the volatile oil is more than or equal to 5%;
the rhubarb extract is an alcohol extract, and anthraquinone substances are more than or equal to 1 percent;
the sophora flavescens extract is an alcohol extract, and the matrine content is more than or equal to 1.5 percent;
the rhizoma cyperi extract is an alcohol extract, and the volatile oil is more than or equal to 2 percent.
Optionally, the acne-removing composition further comprises pharmaceutically acceptable auxiliary materials.
A second aspect of the invention relates to a skin care composition comprising an anti-acne composition as described above.
Optionally, the skin care composition as described above is a lotion, mask, lotion, essence, or cream.
A third aspect of the invention relates to the use of an anti-acne composition as described above for the preparation of a medicament for the treatment of acne.
The composition has high safety, and can not cause skin dryness, desquamation, allergy, and dependence. Meanwhile, the composition has a remarkable acne removing effect and has the effects of moisturizing and acne mark fading. The prepared active extract has light color and good stability, and can achieve the effect by low-content application. The acne-removing traditional Chinese medicine composition is simple and convenient to apply, can be directly applied to cosmetics in various formulations, is not limited to products such as face cleaning products, water products, emulsion products, face cream products, essence products and the like, is low in formula cost, and has wide application prospects.
Detailed Description
Reference will now be made in detail to embodiments of the invention, one or more examples of which are described below. Each example is provided by way of explanation, not limitation, of the invention. In fact, it will be apparent to those skilled in the art that various modifications and variations can be made in the present invention without departing from the scope or spirit of the invention. For instance, features illustrated or described as part of one embodiment, can be used on another embodiment to yield a still further embodiment.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The terminology used in the description of the invention herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. As used herein, the term "and/or" includes any and all combinations of one or more of the associated listed items.
The invention relates to an acne-removing composition which comprises the following components in parts by weight:
0.01-0.5 part of turmeric extract, 0.01-0.3 part of clove extract, 0.02-1 part of salvia miltiorrhiza extract and 0.01-0.3 part of cacumen biotae extract.
In some embodiments, the acne-removing composition of the present invention comprises the following components by weight:
0.1-0.2 part of turmeric extract, 0.05-0.15 part of clove extract, 0.1-0.5 part of salvia miltiorrhiza extract and 0.05-0.15 part of cacumen biotae extract.
In some embodiments, the acne-removing composition of the present invention comprises the following components by weight:
0.15 part of turmeric extract, 0.1 part of clove extract, 0.3 part of salvia extract and 0.1 part of cacumen biotae extract.
In some embodiments, the acne-removing composition of the present invention further comprises the following components by weight:
0.01 to 0.5 part of rhizoma atractylodis extract, 0.01 to 0.5 part of rhubarb extract, 0.01 to 0.7 part of radix sophorae flavescentis extract and 0.01 to 0.3 part of rhizoma cyperi extract.
In some embodiments, the acne-removing composition of the present invention further comprises the following components by weight:
0.1-0.2 part of rhizoma atractylodis extract, 0.1-0.2 part of rhubarb extract, 0.1-0.3 part of radix sophorae flavescentis extract and 0.05-0.15 part of rhizoma cyperi extract.
In some embodiments, the acne-removing composition of the present invention further comprises the following components by weight:
0.15 part of rhizoma atractylodis extract, 0.15 part of rhubarb extract, 0.2 part of radix sophorae flavescentis extract and 0.1 part of rhizoma cyperi extract.
The properties of the raw materials (components) are as follows:
turmeric: pungent and bitter with warm nature. It enters spleen and liver meridians. The functional indications are as follows: break blood and move qi, dredge meridians to alleviate pain. Can be used for treating chest and hypochondrium stabbing pain, thoracic obstruction, cardialgia, dysmenorrhea, amenorrhea, abdominal mass, rheumatism, shoulder and arm pain, and traumatic injury with swelling and pain. In the present invention, turmeric exerts its excellent anti-inflammatory ability, and can prevent the occurrence and deterioration of pox; can soften and moisten skin and delay skin aging; can reduce acne marks and reduce acne aggravation caused by sunlight. The turmeric extract adopted by the invention is preferably a microbial fermentation product (particularly a lactobacillus fermentation product) taking turmeric as a substrate, and further, the total amount of the curcumin and the turmerone is more than or equal to 10 percent (w/w); the amount of the surfactant may be 0.01 to 0.5 parts by weight, for example, 0.05, 0.1, 0.2, 0.3 or 0.4 parts by weight.
Clove: pungent flavor and warm nature. It enters spleen, stomach, lung and kidney meridians. The functional indications are as follows: to warm the middle-jiao and descend the adverse flow of qi, tonify the kidney and strengthen yang. Can be used for treating deficiency-cold of spleen and stomach, singultus emesis, anorexia vomiting and diarrhea, psychroalgia of heart and abdomen, and sexual impotence due to kidney deficiency. In the invention, clove can inhibit the activity of 5 alpha-reductase, reduce the grease secretion caused by higher androgen, and can be used for preventing and treating pox by combining the antibacterial property and the anti-inflammatory property of the clove. Flos Caryophylli has effects of inhibiting collagenase activation, scavenging free radicals, resisting oxidation, and resisting wrinkle and aging. The clove extract adopted by the invention is preferably an alcohol extract, and further, the volatile oil is more than or equal to 8 percent; the amount of the surfactant may be 0.01 to 0.3 parts by weight, for example, 0.05, 0.1, 0.15, 0.2 or 0.25 parts by weight.
Red sage root: bitter in taste and slightly cold in nature. It enters heart and liver meridians. The functional indications are as follows: promoting blood circulation, removing blood stasis, dredging channels, relieving pain, clearing heart fire, relieving restlessness, cooling blood, and eliminating carbuncle. Can be used for treating thoracic obstruction, cardialgia, abdominal pain, hypochondriac pain, abdominal mass, pain due to pyretic arthralgia, vexation, insomnia, menoxenia, dysmenorrhea, amenorrhea, and pyocutaneous disease with swelling and pain. In the present invention, Salvia miltiorrhiza has an antiandrogenic effect and can inhibit sebum secretion. And can inhibit activity of Propionibacterium acnes, reduce skin inflammation, and supplement skin trace elements. The salvia miltiorrhiza extract adopted by the invention is preferably an alcohol extract, and further, the tanshinone content is more than or equal to 5 percent; the amount may be 0.02 to 1 part by weight, for example, 0.05, 0.1, 0.15, 0.2, 0.25, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9 part by weight.
Cacumen biotae: bitter and astringent taste, cold in nature. It enters lung, liver and spleen meridians. The functional indications are as follows: cool blood to stop bleeding, resolve phlegm to stop cough, promote hair growth and blacken hair. Can be used for treating hematemesis, epistaxis, hemoptysis, hematochezia, metrorrhagia, metrostaxis, cough due to lung heat, alopecia due to blood heat, and premature gray hair. In the invention, the cacumen biotae has obvious antibacterial effect and anti-inflammatory activity, and can help skin to lock moisture, shrink pores and maintain the moist and fine state of the skin. The adopted cacumen biotae extract is preferably an alcohol extract, and further, the flavonoid substance is more than or equal to 3 percent; the addition amount of cacumen Platycladi may be 0.01-0.3 parts by weight, for example, 0.05, 0.1, 0.15, 0.2, 0.25 parts by weight.
Rhizoma atractylodis: pungent and bitter with warm nature. It enters spleen, stomach and liver meridians. The functional indications are as follows: dry dampness and invigorate spleen, dispel wind and cold, improve vision. Can be used for treating damp obstruction of middle warmer, abdominal distention, diarrhea, edema, tinea pedis atrophy 36484m, rheumatalgia, wind-cold type common cold, night blindness, dim eyesight, and astringency. In the invention, the rhizoma atractylodis has antibacterial effect on various bacteria, and can prevent and treat acnes; has effects in inhibiting tyrosinase, and can be combined with its antioxidant effect to reduce acne marks. The rhizoma atractylodis extract adopted by the invention is preferably steam distillate, and further, the volatile oil is more than or equal to 5 percent; the amount of rhizoma Atractylodis can be 0.01-0.5 weight parts, such as 0.05, 0.1, 0.2, 0.3, 0.4 weight parts.
Rhubarb: bitter taste and cold nature. It enters spleen, stomach, large intestine, liver and pericardium meridians. The functional indications are as follows: purgation and eliminating accumulation, clearing heat and purging fire, cooling blood and removing toxicity, removing blood stasis and dredging channels, promoting diuresis and eliminating jaundice. Can be used for treating constipation due to excessive heat accumulation, hematemesis, epistaxis, conjunctival congestion, pharyngeal swelling, carbuncle, sore, intestinal carbuncle, abdominal pain, blood stasis, amenorrhea, puerperal blood stasis, traumatic injury, damp-heat dysentery, jaundice, dark urine, stranguria, and edema; it can be used for external treatment of burn and scald. In the invention, the rhubarb plays roles of moisturizing, anti-inflammation and bacteriostasis. The rhubarb extract adopted by the invention is preferably an alcohol extract, and further, anthraquinone substances are more than or equal to 1 percent; the amount of rhubarb added may be 0.01 to 0.5 parts by weight, for example, 0.05, 0.1, 0.2, 0.3, 0.4 parts by weight.
Flavescent sophora root: bitter taste and cold nature. It enters heart, liver, stomach, large intestine and bladder meridians. The functional indications are as follows: clear heat and dry dampness, kill parasites and induce diuresis. Can be used for treating dysentery with heat, hematochezia, jaundice, anuria, leucorrhea with red and white discharge, pudendal swelling, pruritus vulvae, eczema, skin pruritus, scabies, tinea, and leprosy; it can be used for treating trichomonas vaginitis. In the invention, the sophora flavescens has the functions of moisturizing, anti-inflammation and bacteriostasis. The sophora flavescens extract adopted by the invention is preferably an alcohol extract, and furthermore, the matrine is more than or equal to 1.5%; the addition amount of the sophora flavescens can be 0.01 to 0.7 part by weight, for example, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6 part by weight.
Rhizoma cyperi: pungent, slightly bitter, slightly sweet and neutral in nature. It enters liver, spleen and triple energizer meridians. The functional indications are as follows: to soothe the liver, relieve depression, regulate qi, relieve epigastric distention, regulate menstruation and alleviate pain. Can be used for treating stagnation of qi due to depression of the liver, distending pain in chest and hypochondrium, hernia pain, breast pain, stagnation of qi in spleen and stomach, abdominal distention, fullness and pain, menoxenia, amenorrhea, and dysmenorrhea. In the invention, the rhizoma cyperi can effectively calm the skin, thereby achieving the effect of conditioning the skin, strengthening the natural defense system of the skin and ensuring the skin to be moist and comfortable. The rhizoma cyperi extract adopted by the invention is preferably an alcohol extract, and further, the volatile oil is more than or equal to 2 percent; the addition amount of rhizoma Cyperi may be 0.01-0.3 parts by weight, such as 0.05, 0.1, 0.15, 0.2, 0.25 parts by weight.
The raw materials can also contain pharmaceutically acceptable auxiliary materials.
Examples of the pharmaceutically acceptable auxiliary ingredient include binders (syrup, gum arabic, gelatin, sorbitol, tragacanth (tragacanth), polyvinylpyrrolidone and the like), fillers (lactose, sucrose, starch, calcium phosphate, sorbitol, glycine and the like), lubricants (magnesium stearate, talc, polyethylene glycol and the like), disintegrants (starch, microcrystalline cellulose (microcrystalline cellulose), and the like), wetting agents (sodium lauryl sulfate, and the like), suspending agents (sorbitol, syrup, methyl cellulose, glucose syrup, gelatin, hydrogenated edible fat and the like), emulsifiers (lecithin, sorbitol monooleate, gum arabic and the like), non-aqueous carriers (almond oil, fractionated coconut oil, hydrophobic esters of glycerin, propylene glycol, ethanol and the like), preservatives (methyl p-hydroxybenzoate or propyl p-hydroxybenzoate, sodium p-hydroxybenzoate and the like), preservatives (lecithin, sorbitol monooleate, gum arabic and the like), and the like, Sorbic acid, etc.), an aromatic agent (synthetic flavor, natural flavor, etc.), a sweetener (sucrose, stevia, xylitol, etc.), a pH adjuster (sodium hydrogen carbonate, potassium carbonate, etc.), a coloring agent (pigment, dye, etc.), a thickener (gum arabic, methyl cellulose, etc.), an antioxidant (vitamin C, vitamin E, etc.), and the like.
The acne-removing composition can be in various dosage forms, and the preferred dosage forms are ointment, cataplasm or gel.
The ointment is one of the pharmaceutical dosage forms. The unguent is prepared by decocting the above materials with water or vegetable oil, and concentrating. There are oral and external application. The topical ointment includes ointment and plaster. The ointment for external use is called ointment, and is generally prepared by adding beeswax into cottonseed oil or peanut oil, heating to melt, adding the applied medicine fine powder while heating, continuously stirring, and condensing. The ointment is preferably an ointment, cream or patch.
The present invention is preferably an external ointment.
Cataplasm (cataplasma) is a novel external preparation, and is an external preparation for skin application, which is prepared by dissolving or mixing medicines in a water-soluble high polymer material matrix and spreading the mixture on a backing material.
The gel is thick liquid or semisolid preparation prepared by the drug and auxiliary materials capable of forming gel and prepared into solution, suspension or emulsion. Gels are typically topically applied to the skin and body cavities (e.g., nasal, vaginal, and rectal).
The invention also provides a skin care composition containing the acne removing composition.
The acne-removing composition according to the invention may be present in the skin care composition according to the invention in an amount which may be between 0.001% and 10% by weight, preferably between 0.1% and 5% by weight, preferably between 0.5% and 3% by weight, more preferably between 1% and 2% by weight, relative to the total weight of the composition.
In one embodiment, the skin care composition further comprises a physiologically acceptable medium and at least one compound selected from the group consisting of: thickeners, preservatives, fragrances, bactericides, solvents [ e.g. water, alcohols (e.g. ethanol, glycerol, propylene glycol), oils (e.g. mineral, vegetable or animal oils), including in particular C1-C6 alcohols and C2-C10 carboxylic esters ], and carbon-based oils and/or silicone oils (whether of mineral, animal and/or vegetable origin).
The skin care composition additionally comprises a physiologically acceptable medium, i.e., a medium that is free of unpleasant odor, color, or appearance, and does not cause any discomfort (e.g., unacceptable stinging or tautness) to the user. In particular, the composition is suitable for topical application to the skin.
Thus, a "physiologically acceptable medium" is understood to mean a medium compatible with human keratin materials, and in particular with the skin of the body or face.
The compositions according to the invention may comprise any cosmetic adjuvant conventionally used in the fields of application envisaged.
The composition according to the invention may be substantially fluid and may have the appearance of a white or coloured cream, ointment, cream, body cream, lotion (in particular facial cleanser, bath foam), essence, paste, gel or foam. It may optionally be administered in aerosol form. It can also be in solid form, and in particular in the form of a stick. It may also be on a support, for example on a wipe (such as a make-up removal wipe); also for example a face mask.
In particular, in a specific embodiment, the invention also provides a preparation method of the acne-removing essence, which comprises the following steps:
keeping the temperature of the mixed solution of butanediol, glycerol and xanthan gum at 80-100 ℃ for 20-40 min;
adding EDTA salt, allantoin and antiseptic, stirring and cooling to 40-50 deg.C, adding hexanediol and the above-mentioned acne-removing composition.
In some embodiments, the preservative is p-hydroxyacetophenone.
In some embodiments, the acne removing essence comprises 1 to 3 parts by weight of butanediol, 1 to 3 parts by weight of glycerin, 0.1 to 0.2 part by weight of xanthan gum, 0.01 to 0.03 part by weight of EDTA salt, 0.05 to 0.15 part by weight of allantoin and 0.3 to 0.5 part by weight of p-hydroxyacetophenone based on 100 parts by weight of the total amount of the acne removing essence. The addition amount of the acne-removing composition is added according to the weight parts, such as 0.01-0.5 part of turmeric extract, 0.01-0.3 part of clove extract, 0.02-1 part of salvia miltiorrhiza extract, 0.01-0.3 part of cacumen biotae extract, and optionally: 0.01 to 0.5 part of rhizoma atractylodis extract, 0.01 to 0.5 part of rhubarb extract, 0.01 to 0.7 part of radix sophorae flavescentis extract and 0.01 to 0.3 part of rhizoma cyperi extract. The balance being a solvent such as water.
The invention also relates to application of the acne-removing composition in preparation of a medicine for treating acne.
The invention also relates to a method of treating acne comprising topically contacting the skin, and more particularly administering to the facial skin, with an acne-removing composition as described above.
As used herein, the term "treating" includes inhibiting a pathological state, disorder or disease, e.g., arresting or reducing the development of the pathological state, disorder or disease or clinical symptoms thereof; or alleviating the pathological state, disorder or disease, e.g., causing regression of the pathological state, disorder or disease or clinical symptoms thereof. These terms also encompass treatments and cures. Treatment means any manner of ameliorating or otherwise beneficially altering the symptoms of a pathological condition, disorder, or disease. Preferably, the subject in need of such treatment is a mammal, more preferably a human.
For the purposes of the present invention, the term "acne" is intended to mean skin exhibiting acne with an ECLA score of 1 to 36.
Embodiments of the present invention will be described in detail with reference to examples.
Examples
Examples 1 to 8
A traditional Chinese medicine composition for removing acne comprises the following components:
comparative examples 1 to 5
Preparation of a test sample acne removing essence:
1. uniformly dispersing 0.15 part by weight of xanthan gum by using 2 parts by weight of butanediol and 2 parts by weight of glycerol, adding 50 parts by weight of deionized water, heating and stirring to 90 ℃, and preserving heat for 30min to obtain colorless transparent liquid;
2. sequentially adding 0.02 weight part of EDTA disodium, 0.1 weight part of allantoin and 0.4 weight part of p-hydroxyacetophenone, stirring until the EDTA disodium, the allantoin and the p-hydroxyacetophenone are dissolved, and then cooling;
3. cooling to 45 ℃, sequentially adding 0.5 part by weight of hexanediol, the traditional Chinese medicine compositions of the examples 1-8 and the comparative examples 1-5 and the rest of deionized water (the whole formula is 100 parts by weight), and uniformly stirring;
4. cooling to 35 ℃ to obtain the acne removing essence 1-8 and the comparative examples 6-10.
Comparative example 11: the traditional Chinese medicine acne removing essence is commercially available.
Wherein the acne removing essence 1-8 and the comparative examples 6-10 are transparent colorless liquids, and the comparative example 11 is a brown yellow transparent liquid.
Safety
Skin occlusion patch test:
420 volunteers meeting the enrollment criteria were selected for the trial and randomized into 14 groups of 30 individuals each.
Inclusion volunteer criteria were: 1) the age is between 15 and 60 years old, and both men and women can use the health care tea; 2) no serious diseases, no immunodeficiency or autoimmune diseases, and no skin treatment and beauty treatment on the tested part; 3) no active allergic disease; 4) the tested part is not applied with any anti-inflammatory drugs in the last two months; 5) one week later with antihistamine or one month later without immunosuppressant. 6) Those who did not perform the patch test within a month.
Exclusion criteria: 1) pregnant or lactating women; 2) patients with severe diseases of heart, lung, cerebral vessels, liver, kidney and hemopoietic system and mental disease; 3) patients suffering from asthma or other chronic respiratory diseases are being treated.
Abort and exit criteria: during the test, the test sample was not applied as required or the record was not recalled as required.
All volunteers need to sign their informed consent. Marking sample serial numbers on the back surfaces of all spot testers, adding an equal amount of acne-removing essence, taking 0.025ml of sample by using an injector, placing the sample in a medicine chamber of a spot testing adhesive tape, immediately and longitudinally sticking the spot testing adhesive tape with the sample on normal skin of a left forearm from the lower part, and slightly pressing the medicine chamber one by one to expel air so as to uniformly distribute the test substances. The test site is marked for easy observation. Three groups of parallel lines and a blank group are set, the patch is applied once every 24 hours, and the patch is uncovered for a second half hour, and then the examination is performed according to the grading standard. The patch test was performed 6 times in total, and on day 6 after completion of the skin application, additional examination was performed to observe delayed reactions.
Closed patch test skin adverse reaction grading standard
The criteria for the skin irritation test are shown in the table.
The results are shown in the table:
essence 1-8
Comparative examples 6 to 11
And (4) conclusion:
no adverse reaction of human bodies occurs in 1-8 parts of essence and 6-10 parts of comparative examples, and the safety is high. Comparative example 11 three 2-stage reactions occurred. The composition of the invention has mild property and high safety.
(II) stability
And (3) placing the essence 1-8 and the comparative examples 6-11 under different storage conditions for stability observation for 3 months.
The results are shown in the table
Essence 1-8
Storage conditions | Essence 1 | Essence 2 | Essence 3 | Essence 4 | Essence 5 | Essence 6 | Essence 7 | Essence 8 |
50℃ | Without change | Without change | Without change | Is not changedTransforming | Without change | Without change | Without change | Without change |
40℃ | Without change | Without change | Without change | Without change | Without change | Without change | Without change | Without change |
25℃ | Without change | Without change | Without change | Without change | Without change | Without change | Without change | Without change |
5℃ | Without change | Without change | Without change | Without change | Without change | Without change | Without change | Without change |
-18℃ | Without change | Without change | Without change | Without change | Without change | Without change | Without change | Without change |
Natural illumination of light | Without change | Without change | Without change | Without change | Without change | Without change | Without change | Without change |
Comparative examples 6 to 11
Storage conditions | Comparative example 6 | Comparative example 7 | Comparative example 8 | Comparative example 9 | Comparative example 10 | Comparative example 11 |
50℃ | Darkening of color | Darkening of color | Darkening of color | Darkening of color | Darkening of color | The color is very dark |
40℃ | Darkening of color | Darkening of color | Without change | Without change | Without change | Darkening of color |
25℃ | Without change | Without change | Without change | Without change | Without change | Without change |
5℃ | Without change | Without change | Without change | Without change | Without change | A small amount of precipitate is separated out |
-18℃ | Precipitate is separated out | A small amount of precipitate is separated out | Without change | A small amount of precipitate is separated out | A small amount of precipitate is separated out | Precipitate is separated out |
Natural illumination of light | Without change | Without change | Without change | Without change | Without change | Color lightening |
And (4) conclusion:
the essence 1-8 has no color or state change, and is high in stability. Comparative examples 6-11 all showed stability problems of different degrees, especially comparative example 11 showed high temperature, discoloration under illumination and low temperature precipitation. Since comparative example 11 is a brownish yellow transparent liquid, it is suspected that this may be caused by adding a high content of traditional Chinese medicine acne-removing ingredients to the formula to achieve a significant acne-removing effect. The traditional Chinese medicine extract has high ion concentration, and the system is unstable due to high content of the traditional Chinese medicine extract, and meanwhile, the long-term stability of the traditional Chinese medicine extract in a formula system is difficult to ensure due to improper proportion, and discoloration or precipitation occurs. Meanwhile, the comparative examples 6-10 also show state changes of different degrees, and compared with the essence 1-8, the results show that the turmeric extract, the clove extract, the salvia miltiorrhiza extract and the cacumen biotae extract are reasonably matched and have synergistic effect, so that a formula system is more stable.
(III) efficacy
Acne removing, moisturizing and acne mark fading efficacy test
450 volunteers meeting the selection criteria were selected for the trial, and all volunteers were randomly divided into 15 groups of 30 individuals each. The essence is used for 1-8 of all groups of volunteers respectively, the proportion is 6-11, one group of volunteers can normally care skin, no efficacy type skin care product is used, and the group is blank.
Inclusion volunteer criteria were: the age is 20-45 years old, and the nature is not limited; oily and mixed skin, and face with acne; hormone drugs and immunosuppressants have not been used in the last month; the tested part does not participate in other clinical testers at present or in nearly 30 days; can be matched with testers well; the system can read and understand all contents of the informed consent and voluntarily sign the informed consent; during the test period, the consent was not to use any cosmetics, drugs and nutraceuticals that have an impact on the outcome.
Exclusion criteria: open wound or erosion face at the acne affected part; those with high allergic constitution; those with a history of cosmetic allergy; a female who is pregnant, lactating, or intended to be pregnant during the test; severe center of gravity, liver and kidney function damage and severe immunologic hypofunction; those with mental disorders, severe endocrine disorders, and oral contraceptives; the patients who participate in the drug clinical testers or other testers within 30 days, or the patients who have systemic drugs which have influence on the test results within about 1 week; those who had oral and topical cosmetic products within 2 weeks that may have an effect on the outcome of the test; the investigator considered not appropriate for attending the investigator.
Abort and exit criteria: smearing the tested sample or recording the revisit according to the requirement during the test period; has serious diseases or serious adverse reactions during the use period.
All volunteers need to sign their informed consent. The volunteers applied the product on their whole face for 28 days after cleansing the face in the morning and evening each day. The clinical evaluation of the acne removing efficacy of a dermatologist is adopted to obtain the effective number and the cure number of the acne removing patients. Evaluation criteria: 1) and (3) curing: disappearance of clinical symptoms, elimination of pox and pox; 2) the method has the following advantages: the clinical symptoms are relieved, the pox part is eliminated or disappeared, and the reduction or reduction is realized; 3) and (4) invalidation: the clinical symptoms and pox are not improved.
Meanwhile, the volunteers are required to evaluate the effects of moisturizing and acne mark fading by themselves, the score is 0-9 according to the using effect, the score is the best when 9 is the best, and the score is the worst when 0 is the worst, and the average value is taken. Recording the number of effective people for removing acne, moisturizing and removing acne marks on days 1, 3, 7, 14 and 28 after sample trial, and recording the number of cured people on day 28.
The evaluation results of acne-removing efficacy are shown in Table 1
The scoring results of the moisturizing and acne mark removing effects are shown in Table 2
And (4) conclusion:
as can be seen from tables 1 and 2, the acne-removing traditional Chinese medicine composition provided by the essence 1-8 has the remarkable effects of removing acne, preserving moisture and removing acne marks, is quick in acne-removing effect and high in cure rate, and can improve the moisture of skin and remove acne marks after being used for a long time. Compared with the comparative examples 6-11 and the blank group, the essence 3 has a synergistic effect by reasonably proportioning the turmeric extract, the clove extract, the salvia miltiorrhiza extract and the cacumen biotae extract. The comparison of the essence 1-8 shows that the addition of any one or more of the rhizoma atractylodis extract, the rheum officinale extract, the radix sophorae flavescentis extract and the rhizoma cyperi extract can further enhance the effects of removing acnes, preserving moisture and fading acne marks.
The technical features of the embodiments described above may be arbitrarily combined, and for the sake of brevity, all possible combinations of the technical features in the embodiments described above are not described, but should be considered as being within the scope of the present specification as long as there is no contradiction between the combinations of the technical features.
The above-mentioned embodiments only express several embodiments of the present invention, and the description thereof is more specific and detailed, but not construed as limiting the scope of the invention. It should be noted that, for a person skilled in the art, several variations and modifications can be made without departing from the inventive concept, which falls within the scope of the present invention. Therefore, the protection scope of the present patent shall be subject to the appended claims.
Claims (10)
1. The acne-removing composition is characterized by comprising the following components in parts by weight:
0.01-0.5 part of turmeric extract, 0.01-0.3 part of clove extract, 0.02-1 part of salvia miltiorrhiza extract and 0.01-0.3 part of cacumen biotae extract.
2. The acne-removing composition according to claim 1, which comprises the following components in parts by weight:
0.1-0.2 part of turmeric extract, 0.05-0.15 part of clove extract, 0.1-0.5 part of salvia miltiorrhiza extract and 0.05-0.15 part of cacumen biotae extract.
3. The acne-removing composition according to claim 1, wherein:
the turmeric extract is a microbial fermentation product taking turmeric as a substrate, and the total amount of curcumin and turmerone is more than or equal to 10% (w/w);
the clove extract is an alcohol extract, and the volatile oil is more than or equal to 8 percent;
the red sage root extract is an alcohol extract, and the tanshinone content is more than or equal to 5 percent;
the cacumen biotae extract is an alcohol extract, and the flavonoid substance is more than or equal to 3 percent.
4. The acne-removing composition according to claim 1, further comprising the following components by weight:
0.01 to 0.5 part of rhizoma atractylodis extract, 0.01 to 0.5 part of rhubarb extract, 0.01 to 0.7 part of radix sophorae flavescentis extract and 0.01 to 0.3 part of rhizoma cyperi extract.
5. The acne-removing composition according to claim 4, further comprising the following components by weight:
0.1-0.2 part of rhizoma atractylodis extract, 0.1-0.2 part of rhubarb extract, 0.1-0.3 part of radix sophorae flavescentis extract and 0.05-0.15 part of rhizoma cyperi extract.
6. The acne-removing composition according to claim 4, wherein:
the rhizoma atractylodis extract is steam distillate, and the volatile oil is more than or equal to 5 percent;
the rhubarb extract is an alcohol extract, and anthraquinone substances are more than or equal to 1 percent;
the sophora flavescens extract is an alcohol extract, and the matrine content is more than or equal to 1.5 percent;
the rhizoma cyperi extract is an alcohol extract, and the volatile oil is more than or equal to 2 percent.
7. The acne removal composition according to claim 6, further comprising a pharmaceutically acceptable adjuvant.
8. A skin care composition comprising the acne treatment composition according to any one of claims 1 to 7.
9. The skin care composition according to claim 8, which is a lotion, a mask, a lotion, a serum, and a cream.
10. Use of the acne-removing composition according to any one of claims 1 to 7 in the preparation of a medicament for treating acne.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110388109.7A CN113081933A (en) | 2021-04-12 | 2021-04-12 | Acne-removing composition and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110388109.7A CN113081933A (en) | 2021-04-12 | 2021-04-12 | Acne-removing composition and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113081933A true CN113081933A (en) | 2021-07-09 |
Family
ID=76676438
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110388109.7A Pending CN113081933A (en) | 2021-04-12 | 2021-04-12 | Acne-removing composition and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113081933A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115804738A (en) * | 2022-03-30 | 2023-03-17 | 广东格烯生物科技股份有限公司 | Plant acne-removing composition containing radix sophorae flavescentis and salvia miltiorrhiza and preparation method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101524509A (en) * | 2008-03-07 | 2009-09-09 | 大连永兴生物医药孵化器有限公司 | Eliminating acne turmeric gel paste for treating acne |
CN102068498A (en) * | 2010-11-26 | 2011-05-25 | 新时代健康产业(集团)有限公司 | Chinese medicinal composition with acne treatment and anti-inflammation effects, preparation and preparation method thereof |
CN104688637A (en) * | 2013-12-04 | 2015-06-10 | 肖峰 | Red sage root acne-removing repairing cream |
CN108969429A (en) * | 2018-10-16 | 2018-12-11 | 广州科玛生物科技股份有限公司 | A kind of anti-acne essence |
CN109568217A (en) * | 2019-01-30 | 2019-04-05 | 广州诗美化妆品有限公司 | A kind of preparation method of Salvia root P.E and its application in anti-acne |
-
2021
- 2021-04-12 CN CN202110388109.7A patent/CN113081933A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101524509A (en) * | 2008-03-07 | 2009-09-09 | 大连永兴生物医药孵化器有限公司 | Eliminating acne turmeric gel paste for treating acne |
CN102068498A (en) * | 2010-11-26 | 2011-05-25 | 新时代健康产业(集团)有限公司 | Chinese medicinal composition with acne treatment and anti-inflammation effects, preparation and preparation method thereof |
CN104688637A (en) * | 2013-12-04 | 2015-06-10 | 肖峰 | Red sage root acne-removing repairing cream |
CN108969429A (en) * | 2018-10-16 | 2018-12-11 | 广州科玛生物科技股份有限公司 | A kind of anti-acne essence |
CN109568217A (en) * | 2019-01-30 | 2019-04-05 | 广州诗美化妆品有限公司 | A kind of preparation method of Salvia root P.E and its application in anti-acne |
Non-Patent Citations (1)
Title |
---|
王建新: "《化妆品植物原料大全》", 30 June 2012 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115804738A (en) * | 2022-03-30 | 2023-03-17 | 广东格烯生物科技股份有限公司 | Plant acne-removing composition containing radix sophorae flavescentis and salvia miltiorrhiza and preparation method thereof |
CN115804738B (en) * | 2022-03-30 | 2024-06-11 | 广东格烯生物科技股份有限公司 | Plant acne-removing composition containing radix sophorae flavescentis and radix salviae miltiorrhizae and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2018508503A (en) | Acne-removing skin care products and methods for their production | |
CN113171327A (en) | Oil-control acne-removing composition and application thereof | |
CN112426390A (en) | Natural traditional Chinese medicine acne-removing composition and preparation method thereof | |
CN105078829A (en) | Chinese medicinal acne-removing face cream and preparation method thereof | |
CN112426398A (en) | Acne removing composition with acne mark removing effect and preparation method thereof | |
CN106511211B (en) | Anti-inflammatory acne-removing skin-care lotion and preparation method thereof | |
CA3061545A1 (en) | Skin care composition | |
CN112315883B (en) | Skin care composition for controlling oil and removing acne and preparation and application thereof | |
CN104095783A (en) | Traditional Chinese medicine antiphlogistic and acne-removing beauty cream and preparation method thereof | |
CN109939193A (en) | A kind of composition for treating skin eczema, preparation and preparation method and application | |
CN117427012A (en) | Plant compound extract with oil control and tightening effects and application thereof | |
CN113081933A (en) | Acne-removing composition and preparation method and application thereof | |
CN110339249B (en) | Traditional Chinese medicine composition for treating hemorrhoids and anal fissure as well as preparation method and application thereof | |
US20200030398A1 (en) | Skin care composition | |
CN112022767A (en) | Anti-inflammatory antibacterial immunity-enhancing acne-removing composition and application thereof | |
CN106667852A (en) | Traditional Chinese medicine cream for removing acne and preparation method thereof | |
CN102218024B (en) | Blain dispelling composition and application thereof in cosmetic | |
CN116251047A (en) | Oil-control hair-washing agent containing burdock root extract and preparation method thereof | |
KR102071600B1 (en) | Cream composition manufacturing method for preventing of sensitive-skin and skin-trouble | |
KR102071586B1 (en) | Sheet mask pack composition for preventing of sensitive-skin and skin-trouble | |
CN113134068B (en) | Acne-removing composition and preparation method and application thereof | |
CN105616536A (en) | Traditional Chinese medicine liniment for treating leukoderma | |
CN106822300B (en) | Traditional Chinese medicine preparation for removing acne and beautifying face | |
CN105031254A (en) | Ointment used for treating dermatitis and preparation method thereof | |
CN105232437A (en) | Composition and shower gel for skin whitening and preparation method of composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210709 |